Key facts
- Syndax Pharmaceuticals priced $250 million of convertible senior notes due 2029.
- The notes will bear interest at a rate of 2.875% per annum.
Syndax Pharmaceuticals announced it has priced $250 million of its convertible senior notes. These notes are set to mature in 2029 and will carry an annual interest rate of 2.875%. This move allows the company to raise capital through debt financing with the potential for equity conversion.